Binex Co., Ltd. Logo

Binex Co., Ltd.

Biopharmaceutical firm with pharma manufacturing and biologics CDMO services.

053030 | KO

Overview

Corporate Details

ISIN(s):
KR7053030003
LEI:
Country:
South Korea
Address:
부산광역시 사하구 다대로 368-3, 부산광역시

Description

Binex Co., Ltd. is a biopharmaceutical company engaged in two main sectors: synthetic pharmaceuticals and biologics contract services. The pharmaceutical division manufactures and distributes a portfolio of products, including gastrointestinal tract regulators, antispasmodics, and anti-cancer drugs. As a Contract Development and Manufacturing Organization (CDMO), the company provides comprehensive services for biologics, specializing in cell line development, process development, and analytical method development. Its quality management systems are recognized by major international regulatory authorities such as the FDA, EMA, and PMDA, establishing it as a key partner in biopharmaceutical development and manufacturing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.4 KB
2025-12-24 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean HTML 14.0 KB
2025-09-08 00:00
단일판매ㆍ공급계약체결
Korean HTML 9.5 KB
2025-08-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.5 MB
2025-06-30 00:00
단일판매ㆍ공급계약체결
Korean HTML 9.5 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.6 MB
2025-04-30 00:00
소속부변경
Korean HTML 3.6 KB
2025-04-18 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 85.9 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 29.4 KB
2025-03-24 00:00
정기주주총회결과
Korean HTML 23.7 KB
2025-03-24 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 10.2 KB
2025-03-14 00:00
감사보고서제출
Korean HTML 25.5 KB
2025-03-14 00:00
사업보고서 (2024.12)
Korean HTML 2.0 MB
2025-03-05 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean HTML 12.1 KB

Automate Your Workflow. Get a real-time feed of all Binex Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Binex Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Binex Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.